2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase
about
Dysregulated metabolism contributes to oncogenesisPyruvate kinase: Function, regulation and role in cancerM2 pyruvate kinase provides a mechanism for nutrient sensing and regulation of cell proliferation.Combining structure-based pharmacophore modeling, virtual screening, and in silico ADMET analysis to discover novel tetrahydro-quinoline based pyruvate kinase isozyme M2 activators with antitumor activityHow chemoproteomics can enable drug discovery and developmentPET imaging of tumor glycolysis downstream of hexokinase through noninvasive measurement of pyruvate kinase M2.Activators of PKM2 in cancer metabolism.A novel pyruvate kinase M2 activator compound that suppresses lung cancer cell viability under hypoxiaBioluminescence Methods for Assaying Kinases in Quantitative High-Throughput Screening (qHTS) Format Applied to Yes1 Tyrosine Kinase, Glucokinase, and PI5P4Kα Lipid Kinase.Anticancer agents that counteract tumor glycolysis.Global profiling strategies for mapping dysregulated metabolic pathways in cancer.Stalling the engine of resistance: targeting cancer metabolism to overcome therapeutic resistance.miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinomaRegulation and function of pyruvate kinase M2 in cancer.Emerging Approaches for Targeting Metabolic Vulnerabilities in Malignant Glioma.PKM2, a Central Point of Regulation in Cancer Metabolism.Pyruvate kinase activators as a therapy target: a patent review 2011-2017.Photoredox-catalyzed procedure for carbamoyl radical generation: 3,4-dihydroquinolin-2-one and quinolin-2-one synthesis.Inhibitory and Activating Effects of Some Flavonoid Derivatives on Human Pyruvate Kinase Isoenzyme M2.
P2860
Q26784630-3F5F4A65-8840-4CBC-B176-5A33A6BF58F5Q26798084-27D0DEE3-29F6-487F-98EA-59F5B4082851Q27677066-31B19A3F-7127-44D8-B58B-D8B7F675A146Q28655910-90BA8856-4BFF-4A4C-BDEA-E4014E916B5DQ34143272-DAF6348F-F6A5-49A8-B37B-67DA9BBDE450Q34498995-D5C7F8EB-43EE-4A19-A8AB-AA1D59895613Q35215989-11F24764-2627-47FD-9A8A-37C3034C5E0DQ35450863-C395AD7B-0392-4BF4-BFE6-FCA561B77875Q35821339-04AB9585-BAC4-4CE7-ADF8-9DE390124406Q36452381-1DB92C3B-7A16-4E5B-8740-0BE11A1E9F81Q36516956-86B6A825-F075-4DE6-B113-A237945A482DQ36815271-5A34C94D-99CC-4461-9AA9-DD98D67EDD6CQ37510658-440360F7-D1FC-4DDE-97E0-C4E5F2F50480Q37631099-D80438E3-8C59-427C-852D-272F8DD46CAEQ38694204-A0FDC066-ACF8-45A4-B996-0FADC2588CCCQ41669982-8B1D2D7C-72C5-4139-B54B-951250B29E16Q47673139-E285F36A-CB0F-40F2-AB54-FECC7EB0944AQ48198323-BF895087-053D-439A-BE63-33BD3AE88748Q51589905-F5126F03-48C3-4884-9FC1-D06C897D56A2
P2860
2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
2-Oxo-N-aryl-1,2,3,4-tetrahydr ...... M2 isoform of pyruvate kinase
@ast
2-Oxo-N-aryl-1,2,3,4-tetrahydr ...... M2 isoform of pyruvate kinase
@en
2-Oxo-N-aryl-1,2,3,4-tetrahydr ...... M2 isoform of pyruvate kinase
@nl
type
label
2-Oxo-N-aryl-1,2,3,4-tetrahydr ...... M2 isoform of pyruvate kinase
@ast
2-Oxo-N-aryl-1,2,3,4-tetrahydr ...... M2 isoform of pyruvate kinase
@en
2-Oxo-N-aryl-1,2,3,4-tetrahydr ...... M2 isoform of pyruvate kinase
@nl
prefLabel
2-Oxo-N-aryl-1,2,3,4-tetrahydr ...... M2 isoform of pyruvate kinase
@ast
2-Oxo-N-aryl-1,2,3,4-tetrahydr ...... M2 isoform of pyruvate kinase
@en
2-Oxo-N-aryl-1,2,3,4-tetrahydr ...... M2 isoform of pyruvate kinase
@nl
P2093
P2860
P1476
2-Oxo-N-aryl-1,2,3,4-tetrahydr ...... M2 isoform of pyruvate kinase
@en
P2093
Craig J Thomas
Douglas S Auld
Henrike Veith
James M Bougie
Kyle R Brimacombe
Martin J Walsh
Matthew B Boxer
Matthew G Vander Heiden
Thomas Daniel
P2860
P304
P356
10.1016/J.BMCL.2011.08.114
P407
P577
2011-09-14T00:00:00Z